Cargando…

Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models

BACKGROUND: Mesenchymal stromal cells (MSCs) are proven to have immunosuppressive functions via various mechanisms. These mechanisms were demonstrated by administering bone marrow derived human MSCs (hMSCs) to graft versus host disease (GVHD) murine models. METHODS: BALB/c host mice were irradiated...

Descripción completa

Detalles Bibliográficos
Autores principales: Robles, Joseph Delano, Liu, Yin Ping, Cao, Jiamin, Xiang, Zheng, Cai, Yin, Manio, Michael, Tang, Eva HC, Chan, Godfrey Chi-Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440561/
https://www.ncbi.nlm.nih.gov/pubmed/26000204
http://dx.doi.org/10.1186/s40164-015-0007-0
_version_ 1782372660871692288
author Robles, Joseph Delano
Liu, Yin Ping
Cao, Jiamin
Xiang, Zheng
Cai, Yin
Manio, Michael
Tang, Eva HC
Chan, Godfrey Chi-Fung
author_facet Robles, Joseph Delano
Liu, Yin Ping
Cao, Jiamin
Xiang, Zheng
Cai, Yin
Manio, Michael
Tang, Eva HC
Chan, Godfrey Chi-Fung
author_sort Robles, Joseph Delano
collection PubMed
description BACKGROUND: Mesenchymal stromal cells (MSCs) are proven to have immunosuppressive functions via various mechanisms. These mechanisms were demonstrated by administering bone marrow derived human MSCs (hMSCs) to graft versus host disease (GVHD) murine models. METHODS: BALB/c host mice were irradiated prior to receiving C57BL/6 donor T cell depleted bone marrow (TCDBM) cells (negative control) and donor CD4+ T lymphocyte with (treatment group) or without hMSCs (positive control). The presence of hMSCs in target tissues and lymphoid organs was documented by using in vivo imaging and measuring the expression of EphB2 and ephrin-B2 by RTqPCR. Survival rate and GVHD score were also monitored. Tissue sections were obtained for histopathologic analysis. Flow cytometry was used to document donor T cell alloreactivity and expression of CCR5, CXCR3 and CCR7. ELISA was utilized to determine levels of proinflammatory cytokines, RANTES (CCL5) and phosphorylated STAT 5A/B. RTqPCR was performed to quantify expression of CCL3 and CXCL9. Western blotting was performed to qualitatively measure iNOS expression. RESULTS: Survival rate and GVHD score improved with hMSC treatment. Pathologic changes of GVHD were abrogated. Documentation of suppression of RANTES, CCL3, CXCL9, CCR5 and CXCR3 with simultaneous decrease of donor T cell alloreactivity was demonstrated 6 days after transplantation, along with reduction of levels of inflammatory cytokines, suppression of STAT 5A/B phosphorylation, increased expression of CCR7 and increased production of nitrous oxide by hMSCs. Documentation of homing of hMSCs to lymphoid organs and target tissues was also performed. CONCLUSIONS: These mechanisms contribute to the current understanding of MSC mechanisms of immunosuppression and forms a comprehensive picture of how they exert immunosuppression in an in vivo model of immune dysregulation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40164-015-0007-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4440561
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44405612015-05-22 Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models Robles, Joseph Delano Liu, Yin Ping Cao, Jiamin Xiang, Zheng Cai, Yin Manio, Michael Tang, Eva HC Chan, Godfrey Chi-Fung Exp Hematol Oncol Research BACKGROUND: Mesenchymal stromal cells (MSCs) are proven to have immunosuppressive functions via various mechanisms. These mechanisms were demonstrated by administering bone marrow derived human MSCs (hMSCs) to graft versus host disease (GVHD) murine models. METHODS: BALB/c host mice were irradiated prior to receiving C57BL/6 donor T cell depleted bone marrow (TCDBM) cells (negative control) and donor CD4+ T lymphocyte with (treatment group) or without hMSCs (positive control). The presence of hMSCs in target tissues and lymphoid organs was documented by using in vivo imaging and measuring the expression of EphB2 and ephrin-B2 by RTqPCR. Survival rate and GVHD score were also monitored. Tissue sections were obtained for histopathologic analysis. Flow cytometry was used to document donor T cell alloreactivity and expression of CCR5, CXCR3 and CCR7. ELISA was utilized to determine levels of proinflammatory cytokines, RANTES (CCL5) and phosphorylated STAT 5A/B. RTqPCR was performed to quantify expression of CCL3 and CXCL9. Western blotting was performed to qualitatively measure iNOS expression. RESULTS: Survival rate and GVHD score improved with hMSC treatment. Pathologic changes of GVHD were abrogated. Documentation of suppression of RANTES, CCL3, CXCL9, CCR5 and CXCR3 with simultaneous decrease of donor T cell alloreactivity was demonstrated 6 days after transplantation, along with reduction of levels of inflammatory cytokines, suppression of STAT 5A/B phosphorylation, increased expression of CCR7 and increased production of nitrous oxide by hMSCs. Documentation of homing of hMSCs to lymphoid organs and target tissues was also performed. CONCLUSIONS: These mechanisms contribute to the current understanding of MSC mechanisms of immunosuppression and forms a comprehensive picture of how they exert immunosuppression in an in vivo model of immune dysregulation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40164-015-0007-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-30 /pmc/articles/PMC4440561/ /pubmed/26000204 http://dx.doi.org/10.1186/s40164-015-0007-0 Text en © Robles et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Robles, Joseph Delano
Liu, Yin Ping
Cao, Jiamin
Xiang, Zheng
Cai, Yin
Manio, Michael
Tang, Eva HC
Chan, Godfrey Chi-Fung
Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models
title Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models
title_full Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models
title_fullStr Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models
title_full_unstemmed Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models
title_short Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models
title_sort immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in balb/c host graft versus host disease murine models
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440561/
https://www.ncbi.nlm.nih.gov/pubmed/26000204
http://dx.doi.org/10.1186/s40164-015-0007-0
work_keys_str_mv AT roblesjosephdelano immunosuppressivemechanismsofhumanbonemarrowderivedmesenchymalstromalcellsinbalbchostgraftversushostdiseasemurinemodels
AT liuyinping immunosuppressivemechanismsofhumanbonemarrowderivedmesenchymalstromalcellsinbalbchostgraftversushostdiseasemurinemodels
AT caojiamin immunosuppressivemechanismsofhumanbonemarrowderivedmesenchymalstromalcellsinbalbchostgraftversushostdiseasemurinemodels
AT xiangzheng immunosuppressivemechanismsofhumanbonemarrowderivedmesenchymalstromalcellsinbalbchostgraftversushostdiseasemurinemodels
AT caiyin immunosuppressivemechanismsofhumanbonemarrowderivedmesenchymalstromalcellsinbalbchostgraftversushostdiseasemurinemodels
AT maniomichael immunosuppressivemechanismsofhumanbonemarrowderivedmesenchymalstromalcellsinbalbchostgraftversushostdiseasemurinemodels
AT tangevahc immunosuppressivemechanismsofhumanbonemarrowderivedmesenchymalstromalcellsinbalbchostgraftversushostdiseasemurinemodels
AT changodfreychifung immunosuppressivemechanismsofhumanbonemarrowderivedmesenchymalstromalcellsinbalbchostgraftversushostdiseasemurinemodels